AniCura, a leading European provider of high-quality veterinary care for companion animals, is pleased to welcome Mars Petcare as its new owner. As part of the Mars Petcare family, AniCura gains improved opportunities to continue developing advanced veterinary care and medical quality, whilst also benefiting from a long-term perspective, in-depth industrial knowledge and a global veterinary community.
AniCura was established in 2011 by Fidelio Capital and The Animal Hospital Foundation in Greater Stockholm as the first merger of companion animal hospitals in the Nordic region. Over the past seven years, the company has grown to employ more than 4 000 veterinary professionals at 200 animal hospitals and clinics across seven European countries. Today, AniCura is a role model and leading provider of advanced veterinary care, well-known for its investments in quality and people.
- We have been on an amazing journey for the past seven years with strong support from our owners to build a European quality leader. To strengthen our capabilities and continue our rapid development, we look forward to join a family-owned business with deep industrial knowledge and a long-term dedication for pet health. We couldn’t be more excited about partnering with Mars to ensure we provide the best possible veterinary care now and in the future, says Peter Dahlberg, CEO AniCura.
Mars Petcare is a family-owned company with 75 000 employees in more than 50 countries. Pet care has been an important part of Mars for over 80 years and today Mars has a growing veterinary business with approximately 50 000 veterinary professionals globally. The acquisition of AniCura represents Mars Petcare’s strategic entry into the European veterinary care sector. It brings together Mars Petcare’s global veterinary expertise with AniCura’s well-established European business.
- Mars Petcare has a long and global history of providing nutrition, veterinary care and science for pets across the globe. AniCura enjoys an exceptional reputation in the veterinary market with its quality programme, strong corporate culture and high share of referrals. Together with the team at AniCura, we look forward to benefitting from each other’s best practices and competencies, improving clinical practice and continuing to advance the veterinary profession in both Europe and North America. This will support us in our purpose to create a better world for pets, says Poul Weihrauch, President, Mars Petcare.
AniCura’s existing management team, led by CEO Peter Dahlberg, will continue to lead and develop the business with a maintained focus on quality, innovation and entrepreneurship, nurturing a strong, unique culture and taking clinical decisions close to the patient and customer.
Opportunities for knowledge and best practice sharing build on the collective experiences of veterinary care companies such as BluePearl, VCA, Banfield and Pet Partners in North America and Linnaeus in the UK, all part of the Mars Petcare family.
AniCura will continue to operate as a stand-alone business and brand. The acquisition is subject to regulatory approvals.
For further information, please contact
Maria Tullberg, Group Communications Manager AniCura, +46 736 268 886
AniCura is a family of well-known animal hospitals and clinics specialised in veterinary care for companion animals. Born out of the idea that sharing resources creates opportunities for better veterinary care, the company was established in 2011 by Fidelio Capital and The Animal Hospital Foundation in Greater Stockholm as the first merger of companion animal hospitals in the Nordic region. Today, AniCura is a role model within specialised veterinary care and a valued partner for pet owners and referring veterinarians across Europe.
AniCura offers a wide range of high quality medical services covering preventive and basic health care as well as advanced diagnostics, internal medicine, intensive care, surgery and orthopaedics. AniCura also provides rehabilitation, physiotherapy and dietary advice and offers selected pet food and care products.
AniCura provides modern, high-quality veterinary care for pets at 200 European locations and creates peace of mind for pet owners through excellent access and patient safety. Every year, AniCura’s 4 000 passionate veterinary professionals attend to more than two million companion animal patients. AniCura is a trusted training and referral body.
AniCura is majority owned by Nordic Capital. Other notable owners include Fidelio Capital and the Animal Hospital Foundation in Greater Stockholm (Stiftelsen Djursjukhus i Stor-Stockholm).
For information on how AniCura is working to shape the future of veterinary care, please visit our website www.anicuragroup.com
About Mars Petcare
Mars Petcare is a diverse and growing business with 75 000 Associates across 50+ countries dedicated to one purpose: A BETTER WORLD FOR PETS. With 75 years of experience, our portfolio of almost 50 brands serves the health and nutrition needs of the world’s pets – including brands ROYAL CANIN®, NUTRO™, PEDIGREE®, WHISKAS®, GREENIES™, SHEBA®, CESAR®, IAMS™ and EUKANUBA™ as well as The WALTHAM Centre for Pet Nutrition which has advanced research in the nutrition and health of pets for over 50 years. Mars Petcare is also a leading veterinary health provider through a network of over 2 000 pet hospitals including VCA™, BLUEPEARL™, BANFIELD™ and PET PARTNERS™. We’re also active in innovation and technology for pets, with WISDOM PANEL™ genetic health screening and DNA testing for dogs, the WHISTLE™ GPS dog tracker, and LEAP VENTURE STUDIO accelerator and COMPANION FUND™ programs that drive innovation and disruption in the pet care industry. As a family business and guided by our principles, we are privileged with the flexibility to fight for what we believe in – and we choose to fight for A BETTER WORLD FOR PETS.